Suchergebnisse - "Galluzzo, Marco"

PubPharm (6)

1

Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy

enthalten in: Dermatitis : contact, atopic, occupational, drug | 2022

von Chiricozzi, A. | Di Nardo, L. | Talamonti, M. | +40

2

Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents

enthalten in: Expert opinion on biological therapy | 2021

von Talamonti, M. | Galluzzo, M.

3

Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy : Data from the DA-COVID-19 registry

enthalten in: Allergy | 2021

von Chiricozzi, A. | Talamonti, M. | De Simone, C. | +69

4

Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic : Risk analysis from the PSO-BIO-COVID observational study

enthalten in: Expert opinion on biological therapy | 2021

von Talamonti, M. | Galluzzo, M. | Chiricozzi, A. | +70

5

Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy : Data from the DA‐COVID‐19 registry

enthalten in: Allergy | 2021

von Chiricozzi, A. | Talamonti, M. | De Simone, C. | +39

6

Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era

enthalten in: Expert opinion on biological therapy | 2020

von Galluzzo, M. | Tofani, L. | Bianchi, L. | +1

1
[1]